about
Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7/ADR cells through autophagy induction: More than just down-regulation of MDR1.Outcomes of re-treatment with first-line trastuzumab plus a taxane in HER2 positive metastatic breast cancer patients after (neo)adjuvant trastuzumab: A prospective multicenter study.Predicting and Overcoming Chemotherapeutic Resistance in Breast Cancer.
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Resistance to Anti-HER2 Therapies in Breast Cancer.
@en
type
label
Resistance to Anti-HER2 Therapies in Breast Cancer.
@en
prefLabel
Resistance to Anti-HER2 Therapies in Breast Cancer.
@en
P1476
Resistance to Anti-HER2 Therapies in Breast Cancer
@en
P2093
Mothaffar F Rimawi
Rachel Schiff
P304
P356
10.14694/EDBOOK_AM.2015.35.E157
P577
2015-01-01T00:00:00Z